Novo Nordisk A/S Class B (NOVOb)

906.1 +19.1 (+2.15%)
Closed DKK Disclaimer

Novo Nordisk A/S Class B Company Profile

Equity Type
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Contact Information
Bagsvaerd,2880 Denmark
45 44 44 88 88
Top Executives
Helge Lund 62 2017 Independent Chairman of the Board
Thomas Rantzau 51 2018 Employee Representative Non-Independent Director
Andreas Fibig 61 2018 Independent Director
Henrik Poulsen 56 2021 Vice Chairman of the Board
Laurence M. Debroux 54 2019 Independent Director
Liselotte Hyveled 57 2022 Employee Representative Director
Mette Bojer Jensen 48 2014 Employee Non-Independent Representative Director
Jesper Thorning 0 2018 Substitute Director
Elisabeth Dahl Christensen 58 2022 Employee Representative Director
Anders Kaae 0 2018 Substitute Director
Martin W. MacKay 67 2018 Independent Director
Sylvie L. Gregoire 63 2015 Independent Director
Tanja Villumsen 43 2018 Substitute Director
Karina Bonde Lenau 0 2018 Substitute Director
Christina Law 56 2022 Independent Director
Kasim Kutay 59 2017 Non-Independent Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.